Cargando…
Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics
If the goal of eliminating dog-mediated human rabies by 2030 is to be achieved, effective mass dog vaccination needs to be complemented by effective prophylaxis for individuals exposed to rabies. Aptamers and short-interfering RNAs (siRNAs) have been successful in therapeutics, but few studies have...
Autores principales: | Scott, Terence Peter, Nel, Louis Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150346/ https://www.ncbi.nlm.nih.gov/pubmed/34064911 http://dx.doi.org/10.3390/v13050881 |
Ejemplares similares
-
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012) -
Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006) -
Lyssaviruses and the Fatal Encephalitic Disease Rabies
por: Scott, Terence Peter, et al.
Publicado: (2021) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017) -
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
por: Dinis Ano Bom, Ana Paula, et al.
Publicado: (2019)